Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Estrogen receptor-α in medial amygdala neurons regulates body weight.

The Journal of clinical investigation | 2015

Estrogen receptor-α (ERα) activity in the brain prevents obesity in both males and females. However, the ERα-expressing neural populations that regulate body weight remain to be fully elucidated. Here we showed that single-minded-1 (SIM1) neurons in the medial amygdala (MeA) express abundant levels of ERα. Specific deletion of the gene encoding ERα (Esr1) from SIM1 neurons, which are mostly within the MeA, caused hypoactivity and obesity in both male and female mice fed with regular chow, increased susceptibility to diet-induced obesity (DIO) in males but not in females, and blunted the body weight-lowering effects of a glucagon-like peptide-1-estrogen (GLP-1-estrogen) conjugate. Furthermore, selective adeno-associated virus-mediated deletion of Esr1 in the MeA of adult male mice produced a rapid body weight gain that was associated with remarkable reductions in physical activity but did not alter food intake. Conversely, overexpression of ERα in the MeA markedly reduced the severity of DIO in male mice. Finally, an ERα agonist depolarized MeA SIM1 neurons and increased their firing rate, and designer receptors exclusively activated by designer drug-mediated (DREADD-mediated) activation of these neurons increased physical activity in mice. Collectively, our results support a model where ERα signals activate MeA neurons to stimulate physical activity, which in turn prevents body weight gain.

Pubmed ID: 26098212 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: T32CA059268
  • Agency: NCI NIH HHS, United States
    Id: T32 CA059268
  • Agency: NICHD NIH HHS, United States
    Id: U54 HD083092
  • Agency: NIDDK NIH HHS, United States
    Id: U19 DK062434
  • Agency: NICHD NIH HHS, United States
    Id: P30 HD024064
  • Agency: NIDDK NIH HHS, United States
    Id: R56 DK109194
  • Agency: NIGMS NIH HHS, United States
    Id: R25 GM056929
  • Agency: NIDDK NIH HHS, United States
    Id: DK5U19DK062434
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK093587
  • Agency: NICHD NIH HHS, United States
    Id: P30HD024064
  • Agency: NIDDK NIH HHS, United States
    Id: R00DK085330
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK092605
  • Agency: NIDDK NIH HHS, United States
    Id: DK59820
  • Agency: NIDDK NIH HHS, United States
    Id: R01DK092605
  • Agency: NIDDK NIH HHS, United States
    Id: R01DK101379
  • Agency: NIDDK NIH HHS, United States
    Id: P01 DK088761
  • Agency: NIDDK NIH HHS, United States
    Id: R01DK093587
  • Agency: NIDDK NIH HHS, United States
    Id: R00 DK085330
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK101379

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Opioid Receptor-Mu (MOR) Antibody (antibody)

RRID:AB_572251

This polyclonal targets Synthetic rat MOR1 (384-398)

View all literature mentions